Zheng Xiao Selected Research

ras-GRF1 (ras GRF1)

10/2018	RASgrf1, a Potential Methylatic Mediator of Anti-epileptogenesis?
7/2017	Association of RASgrf1 methylation with epileptic seizures.
2/2013	Decreased expression of Ras-GRF1 in the brain tissue of the intractable epilepsy patients and experimental rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zheng Xiao Research Topics

Disease

22	Epilepsy (Aura) 01/2022 - 01/2008
20	Neoplasms (Cancer) 01/2022 - 04/2012
13	Seizures (Absence Seizure) 01/2022 - 01/2008
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2021 - 11/2016
8	Drug Resistant Epilepsy 12/2014 - 01/2006
7	Fibrosis (Cirrhosis) 01/2021 - 01/2015
6	Lung Neoplasms (Lung Cancer) 06/2022 - 08/2016
6	Pituitary Neoplasms (Pituitary Adenoma) 07/2020 - 04/2012
6	Temporal Lobe Epilepsy 02/2015 - 06/2009
5	Prolactinoma (Prolactinomas) 07/2020 - 04/2012
4	Malignant Pleural Effusion 06/2022 - 06/2020
4	Infections 01/2021 - 10/2013
4	Carcinogenesis 03/2020 - 01/2018
3	Essential Tremor (Essential Tremors) 01/2022 - 01/2021
3	Body Weight (Weight, Body) 01/2022 - 01/2018
3	Fever (Fevers) 01/2022 - 08/2018
2	Disease Progression 06/2022 - 03/2020
2	Drug-Related Side Effects and Adverse Reactions 01/2022 - 11/2018
2	Cardiac Arrhythmias (Arrythmia) 01/2022 - 05/2016
2	Sepsis (Septicemia) 12/2021 - 12/2021
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2018
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2019
2	Glioma (Gliomas) 01/2021 - 01/2017
2	Ureteral Obstruction 11/2020 - 10/2019
2	Encephalitis (Encephalitis, Rasmussen) 01/2020 - 09/2010
2	Autoimmune Diseases of the Nervous System 01/2020 - 01/2019
2	Neutropenia 10/2019 - 02/2019
2	Thrombocytopenia (Thrombopenia) 10/2019 - 02/2019
2	Glioblastoma (Glioblastoma Multiforme) 08/2015 - 11/2013
2	Glaucoma 02/2010 - 05/2007
1	Iron Overload 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Heart Failure 01/2022
1	Tremor (Tremors) 01/2022
1	Atrial Fibrillation 12/2021
1	Endotoxemia 12/2021
1	Necrosis 12/2021
1	Pulmonary Edema 07/2021

Drug/Important Bio-Agent (IBA)

11	Pharmaceutical PreparationsIBA 01/2021 - 09/2010
8	Proteins (Proteins, Gene)FDA Link 12/2021 - 02/2009
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2009
6	Biological ProductsIBA 01/2020 - 08/2016
6	Anticonvulsants (Antiepileptic Drugs)IBA 08/2019 - 09/2012
5	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2017
5	MicroRNAs (MicroRNA)IBA 03/2020 - 01/2018
5	MethyltransferasesIBA 01/2020 - 02/2012
4	norcantharidinIBA 01/2021 - 01/2015
3	CytokinesIBA 12/2021 - 05/2016
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 01/2019
3	Long Noncoding RNAIBA 01/2021 - 01/2017
3	Dopamine Agonists (Dopamine Agonist)IBA 07/2020 - 01/2019
3	mesoglycanIBA 10/2019 - 08/2016
3	ras-GRF1 (ras GRF1)IBA 10/2018 - 02/2013
3	Kainic Acid (Kainate)IBA 10/2018 - 12/2014
3	Pilocarpine (Ocusert)FDA LinkGeneric 02/2015 - 09/2014
2	Peptides (Polypeptides)IBA 06/2022 - 10/2019
2	Heme (Haem)IBA 01/2022 - 12/2021
2	Dynamin IIBA 01/2022 - 02/2015
2	Messenger RNA (mRNA)IBA 01/2022 - 10/2019
2	IronIBA 01/2022 - 12/2021
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 12/2021 - 07/2014
2	Gemcitabine FDA Link 01/2021 - 01/2017
2	EnzymesIBA 01/2021 - 09/2010
2	InterleukinsIBA 01/2021 - 07/2014
2	Cantharidin (Cantharides)IBA 01/2021 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020 - 05/2016
2	ProlactinIBA 07/2020 - 11/2019
2	CateninsIBA 06/2020 - 01/2019
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 02/2012
2	LuciferasesIBA 11/2019 - 01/2019
2	salicylhydroxamic acid (SHAM)IBA 10/2019 - 05/2016
2	RNA (Ribonucleic Acid)IBA 10/2019 - 01/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2019 - 11/2018
2	AntibodiesIBA 01/2019 - 10/2009
2	RG108IBA 10/2018 - 07/2017
2	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 02/2009
2	Temozolomide (Temodar)FDA LinkGeneric 08/2015 - 11/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2013 - 04/2012
2	tetranectinIBA 04/2010 - 02/2009
2	Apolipoproteins E (ApoE)IBA 03/2010 - 05/2007
2	ApolipoproteinsIBA 02/2009 - 05/2007
1	dapagliflozinIBA 01/2022
1	MonocrotalineIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	staphylococcal enterotoxin CIBA 01/2022
1	CalciumIBA 12/2021
1	metal transporting protein 1 (ferroportin)IBA 12/2021
1	ferrostatin-1IBA 12/2021
1	Interleukin-1 (Interleukin 1)IBA 12/2021
1	Human Serum Albumin FDA LinkGeneric 07/2021

Therapy/Procedure

10	Therapeutics 01/2022 - 01/2009
10	Drug Therapy (Chemotherapy) 01/2020 - 11/2016
3	Radiotherapy 08/2018 - 12/2012
2	Pleurodesis 06/2022 - 01/2022
2	Adjuvant Chemotherapy 05/2021 - 08/2016
2	Immunotherapy 01/2021 - 01/2019
2	Microspheres (Microsphere) 01/2017 - 08/2015
2	Aftercare (After-Treatment) 01/2014 - 10/2013